Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
Aspivix CEO Mathieu Horras Discusses How Much IUD Insertion Can Hurt Less on X-Health.show
Renens, Switzerland - 3 October 2023 - Mathieu Horras, CEO of Aspivix, recently joined Alex Jani on the X-Health.show podcast to delve into pressing issues and innovations in women's healthcare concerning IUD...
Aspivix mentioned in MD+DI – “Removing the Pain from ‘Just a Little Pinch’ Gynecological Procedures”
Read the MD+DI (Medical Device and Diagnostic Industry) article here
Aspivix Featured in Forbes France Following Top 10 Placement at Inaugural MedFemTech Congress
Renens, Switzerland – 10 May 2023 – ASPIVIX SA, a leading Swiss startup in women's healthcare, is thrilled to announce its feature in Forbes France after securing a spot in the top...
ASPIVIX Announces That Contraception, an International Reproductive Health Journal, Has Published First-In-Women Results Using Novel Cervical Stabilizer In IUD Procedures
Renens, Switzerland – 13 March 2023 – ASPIVIX SA, an innovator and developer of medical technologies to advance gynecological and fertility care, today announced the publication of the results in Contraception, an...
Aspivix receives U.S. FDA 510(k) Clearance for Carevix™, Their Novel Cervical Stabilizer
Renens, Switzerland – 26 January 2023 – ASPIVIX SA, an innovator and developer of medical technologies to advance gynecological care, today announced that Carevix™, its novel Atraumatic Cervical Stabilizer, has received 510(k)...
Aspivix mentioned in Femtech World about Serie A
Read the Femtech World article here
